Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 2, 2008, Pages 203-208

  Cao, Hai Xia ^a   Gao, Chang Ming ^a   Takezaki, Toshiro ^b   Wu, Jian Zhong ^a   Ding, Jian Hua ^a   Liu, Yan Ting ^a   Li, Su Ping ^a   Su, Ping ^a   Cao, Jia ^c   Hamajima, Nobuyuki ^d   Tajima, Kazuo ^e  

^a JIANGSU CANCER HOSPITAL   (China)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Colorectal cancer; Genomic polymorphism; Methylenetetrahydrofolate reductase

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHINA; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RECTUM; RISK FACTOR; SMOKING;

ADULT; AGED; CASE-CONTROL STUDIES; CHINA; COLON; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECTUM; RISK FACTORS; SMOKING;

EID: 59849117424     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bailey LB, Gregory JF III (1999). Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr, 129, 919-22.
2. Chen J, Giovannucci E, Kelsey K, et al (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res, 56, 4862-4.
3. Fodinger M, Horl WH, Sunder-Plassmann G (2000). Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol, 13, 20-33.
4. Friso S, Choi SW, Girelli D, et al (2002). A common mutation in the 5,10- methylenetetrahydrofolate reductase gene affects Genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA, 99, 5606-11.
5. Frosst P, Blom HJ, Milos P, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in Methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
6. Gao C, Wu J, Ding J, et al (2002). Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 23, 289-92.
7. Gao C, Takezaki T, Wu J, et al (2003). Methylenetetrahydrofolate reductase genotypes, dietary habits and susceptibility of stomach cancer. Tumor, 29, 95-8.
8. Gao CM, Wu JZ, Liu YT, et al (2003). Interactions between lifestyle, methylanetetrahydrofolate reductase gene and polymorphisms in thymidylate synthase gene with risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 24, 599-603.
9. Gao CM, Toshiro T,Wu JZ, et al (2004). A case-control study on the polymorphisms of methylenetetrahydrofolate reductase 1298A-->C and susceptibility of esophageal cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 25, 341-5.
10. Jiang QT, Chen K, Ma XY, et al (2004). A case-control study on the polymorphisms of methylenetetrahydrofolate reductases, drinking interaction and susceptibility in colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 25, 612-6.
11. Kim DH, Ahn YO, Lee BH, et al (2004). Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett, 216, 199-205.
12. Ma J, Stampfer MJ, Giovannucci E, et al (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res, 57, 1098-102.
13. Park KS, Mok JW, Kim JC (1999). The 677C > T mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test, 3, 233-6.
14. Slattery ML, Potter JD, Samowitz W, et al (1999). Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 8, 513-8.
15. Slattery ML, Samowitz W, Curtin K, et al (2004). Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev, 13, 1206-14.
16. Slattery ML, Murtaugh MA, Sweeney C, et al (2005). PPARgamma, energy balance, and associations with colon and rectal cancer. Nutr Cancer, 51, 155-61.
17. Stern LL, Mason JB, Selhub J, et al (2000). Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylentetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9, 849-53.
18. Ulrich CM, Kampman E, Bigler J, et al (1999). Colorectal adenomas and the C677T MTHFR polymorphism: Evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev, 8, 659-68.
19. Van der Put NM, Gabreels F, Stevens EM, et al (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet, 62, 1044-51.
20. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72.
21. Wu J, Gao C, Ding J, et al (2002). Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of esophageal cancer. Tumor, 22, 268-70.
22. Zhang TZ, Xu GW (1996). Oncology (volume 2). Tianjin: Sciences Technology Press, S1629.